By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    An Expert’s Guide To Building and Improving Endurance
    June 30, 2022
    medical assistants
    What Do Medical Assistants Do On a Day to Day Basis?
    April 5, 2022
    superfoods to help with prostate health
    10 Healthy Foods That Can Help Protect Your Prostate
    August 29, 2022
    Latest News
    Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
    July 20, 2025
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    pfizer and clinical data transparency
    Pfizer to Expand Clinical Trial Data Access, Takes Step Toward Transparency
    December 6, 2013
    Improving Healthcare Services And Management Through Tech Integration
    June 9, 2020
    obamacare and the uninsured
    Why Hospitals Are Still Gouging the Uninsured
    January 7, 2014
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Twitter Recognizes Boehringer Ingelheim as a Pioneer
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Twitter Recognizes Boehringer Ingelheim as a Pioneer
BusinessMedical EducationSocial Media

Twitter Recognizes Boehringer Ingelheim as a Pioneer

Paul Tunnah
Paul Tunnah
Share
4 Min Read
Twitter Recognizes Boehringer Ingelheim
SHARE

Twitter Recognizes Boehringer IngelheimI have written previously about how powerful I think Twitter is as a channel for a regulated industry like pharmaceuticals.

Twitter Recognizes Boehringer IngelheimI have written previously about how powerful I think Twitter is as a channel for a regulated industry like pharmaceuticals. It allows social media engagement with multiple personnel, but in controlled fashion that allows pharma companies to deal with problems in a controlled and compliant way.

Apparently one of the people who read that piece worked at Twitter and, unsurprisingly, they agreed with me!

It is great to therefore see the first business case study from the pharmaceutical industry appear on the Twitter.com website, featuring the work that social media pioneer Boehringer Ingelheim has been doing in using the social media channel to connect with other healthcare stakeholders.

More Read

Creating a Living Laboratory Together [VIDEO]
FDA Warning Letter: Don’t Make Unsubstantiated Claims, Even on Facebook
Living and Working Social: Good or Bad Medicine for Healthcare?
Curmudgeons and Physician Branding: Dr. Russell Faust
Improving Healthcare Costs Through Smarter Utilization of Hospice Care

The specific case study presented by Twitter is from the #COPDchat tweetchats that Boehringer Ingelheim has been running, but could equally have covered its engaging work in the atrial fibrillation or lung cancer space (which I am proud to have been involved in).

Of course, in keeping within the right regulatory guidelines that prevent direct prescription medicines promotion to patients outside the US, Boehringer’s work has focussed on tackling disease awareness issues and gathering research input from involved groups such as patient advocates, healthcare providers and disease associations, rather than discussing the merits of individual treatments.

Here, Boehringer Ingelheim outlines how it used Twitter to both approach and engage with relevant parties, positioning the discussion alongside a relevant medical conference – in this case the European Respiratory Society Congress (#ERS2013). In addition, promoted tweets were used to target specific attendees at the event, matching for keywords such as ‘asthma’ and ‘COPD’ as flags for relevance.

Links to press releases and further information were then used to provide additional background above and beyond the 140 characters permissible within a tweet, all of which sparked interest in the live tweetchat debate held during the congress.

And the results?

Well, the quantitative stats are pretty impressive. 1.7m tweetchat impressions from the hour’s live event, almost 500 mentions of Boehringer at the Congress and 1,200 new followers secured.

But the real story here is in the qualitative feedback gained from this tweetchat, and the numerous others Boehringer has run. Through such discussion the company gained valuable feedback on the market, which was spur-of-the-moment and reactive to developments at the Congress itself, in addition to opening doors with new organisations and individuals that can help its mission in the COPD space.

Twitter identified three key lessons from Boehringer’s work on tweetchats for other pharmaceutical companies:

  1. Align such online discussion with relevant offline events, like the Congress.
  2. Involve key internal stakeholders to ensure regulatory compliance.
  3. Be innovative – don’t be afraid to be the first in your sector rather than waiting for others.

With such prominence, quite rightly so, being given to Boehringer’s work it is time for other pharma companies to step up and also start driving such activities. Every pharma company is talking about being customer- and patient-focussed, and indeed the individuals working within these companies are passionate about making a difference, so communications teams need to start facilitating more of this work.

Boehringer has cut a path through the long grass for the rest of the industry. It’s time for others to start walking in their footsteps to help ensure everyone in healthcare can share their views on developing better medicines.

TAGGED:Boehringer Ingelheimpharmatwitter
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

botox certification
Help Improve People’s Skin Health Via Botox Certification
Skin Specialties
July 22, 2025
Telemedicine Apps
Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
Health
July 20, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025

You Might also Like

Express Scripts-Medco Merger — Antitrust?

July 21, 2011

Standards of Decency in the Blogosphere

June 25, 2014
top 7 icd10 resources
BusinessHospital AdministrationPolicy & Law

The Top 7 ICD-10 Implementation Resources

January 6, 2014
Primary care
BusinessFinanceHospital Administration

Physicians, Health Systems and the Drive for Market Dominance

May 24, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?